Trial Profile
Efficacy of belimumab in patients with systemic lupus erythematosus skin manifestations: A case series
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Apr 2018
Price :
$35
*
At a glance
- Drugs Belimumab (Primary)
- Indications Systemic lupus erythematosus
- Focus Therapeutic Use
- 17 Apr 2018 New trial record